MetaADEDB 2.0 @ LMMD
nafamostat
(SRXKIZXIRHMPFW-UHFFFAOYSA-N)
Structure
SMILES
CS(=O)(=O)O.CS(=O)(=O)O.NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N
Molecular Formula:
C21H25N5O8S2
Molecular Weight:
539.582
Log P:
5.6182
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
6
TPSA:
266.07
CAS Number(s):
82956-11-4
Synonym(s)
1.
nafamostat
2.
6'-amidino-2-naphthyl 4-guanidinobenzoate
3.
FUT 175
4.
FUT-175
5.
nafamostat dihydrochloride
6.
nafamostat mesilate
7.
nafamostat mesylate
8.
nafamstat mesilate
External Link(s)
MeSHC032855
PubChem Compound11961431
5311180
CHEMBLCHEMBL3989553
KEGGdr:D01670
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AcidosisOFFSIDES
2Alanine Aminotransferase IncreasedOFFSIDES
3Altered state of consciousnessOFFSIDES
4ApathyOFFSIDES
5AspergillosisOFFSIDES
6AutomatismOFFSIDES
7Blood alkaline phosphatase increasedOFFSIDES
8Blood amylase increasedOFFSIDES
9Blood chloride decreasedOFFSIDES
10Blood creatine phosphokinase increasedOFFSIDES
11Blood creatinine increasedOFFSIDES
12Blood lactate dehydrogenase increasedOFFSIDES
13Blood potassium decreasedOFFSIDES
14Blood sodiumOFFSIDES
15Blood triglycerides increasedOFFSIDES
16Blood urea increasedOFFSIDES
17Blood uric acid decreasedOFFSIDES
18Bone painOFFSIDES
19BradycardiaOFFSIDES
20Brain natriuretic peptide increasedOFFSIDES
21Chronic ulcerative colitisOFFSIDES
22Colonic StenosisOFFSIDES
23Cytomegalovirus test positiveOFFSIDES
24Depressed Level of ConsciousnessOFFSIDES
25Diabetes InsipidusOFFSIDES
26DiarrheaOFFSIDES
27Disseminated Intravascular CoagulationOFFSIDES
28EnterocolitisOFFSIDES
29EpidermolysisOFFSIDES
30EpistaxisOFFSIDES
31Gamma-Glutamyltransferase IncreasedOFFSIDES
32Gastrointestinal hypomotilityOFFSIDES
33HemothoraxOFFSIDES
34Heparin-induced thrombocytopeniaOFFSIDES
35Incorrect route of drug administrationOFFSIDES
36Kidney FailureOFFSIDES
37LeukoencephalopathyOFFSIDES
38Liver AbscessOFFSIDES
39Metabolic acidosisOFFSIDES
40Muscle enzymeOFFSIDES
41OliguriaOFFSIDES
42Pain of skinOFFSIDES
43PancreatitisOFFSIDES
44Pneumocystis jiroveci pneumoniaOFFSIDES
45Portal Vein ThrombosisOFFSIDES
46Pulmonary HypertensionOFFSIDES
47Renal tubular necrosisOFFSIDES
48Respiratory FailureOFFSIDES
49Retinal Vein OcclusionOFFSIDES
50Therapy non-responderOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.